Megola Signs Remediation Deal with Stat Sanitizing

8 months ago

USA master distribution for leader in odor remediation servicesBONITA SPRINGS, FL / ACCESSWIRE / August 28, 2023 / (OTC PINK:MGON)…

Peregrine Health Services Adds Nationally Known Experts to Its Emergency Department, Trauma Center Consulting Team

8 months ago

Dr. Douglas Slakey and Michael S. Brown join the firm as strategic advisors to help emergency departments and trauma centers…

Jaguar Health to Present September 7 at Emerging Growth Conference and at the September 11-13 H.C. Wainwright Annual Global Investment Conference

8 months ago

Napo Pharmaceuticals, a Jaguar family company, reported completion August 17 of last patient last visit for its pivotal Phase 3…

Oncocyte’s VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage

8 months ago

First digital-droplet PCR assay to receive coverageExpect initial revenue generation in Q1 2024IRVINE, CA / ACCESSWIRE / August 28, 2023…

GLUCOTRACK ANNOUNCES NEW VP OF MARKETING

8 months ago

Rutherford, NJ, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company…

Prominent Casana Executives Named to Prestigious American Heart Association Boards

8 months ago

Chief Operating Officer, Alongside Co-founder and Chief Research Officer, Assume Roles on AHA Boards in Rochester and BostonROCHESTER, N.Y., Aug.…

Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss the Need for New Alcohol Use Disorder Treatments at the European Society for Biomedical Research on Alcoholism

8 months ago

CHARLOTTESVILLE, Va., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage…

T2 Biosystems Praises CDC’s Actions Aimed at Optimizing U.S. Hospital Sepsis Programs

8 months ago

The U.S. Centers for Disease Control and Prevention Releases 2023 Hospital Sepsis Program Core ElementsLEXINGTON, Mass., Aug. 28, 2023 (GLOBE…

NurExone Reports Second Quarter 2023 Financial Results and Provides Corporate Update

8 months ago

Completed the first tranche of a non-brokered private placement offering of units for gross proceeds of approximately CAD$1.3 million to…

Fierce Biotech Names Cerevance a “Fierce 15” Biotech Company of 2023

8 months ago

BOSTON, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on advancing novel,…